Corbus Pharmaceuticals Holdings, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | — | $5.9M | $6.3M |
| FY2015 | — | $9.0M | $12.3M |
| FY2016 | — | $8.9M | $15.0M |
| FY2017 | — | $57.8M | $62.5M |
| FY2018 | — | $27.5M | $41.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | — | $5.9M | $6.3M |
| FY2015 | — | $9.0M | $12.3M |
| FY2016 | — | $8.9M | $15.0M |
| FY2017 | — | $57.8M | $62.5M |
| FY2018 | — | $27.5M | $41.7M |